Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany

Infection

Volumn 40, Issue 4, 2012, Pages 451-454

  Pfefferle, S ^a   Frickmann, H ^b   Gabriel, M ^b   Schmitz, N ^a   Gunther S ^b   Schmidt Chanasit, J ^b  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Acute hepatitis; Chronic B cell leukemia; Fatal course; Hemodialysis; Hepatitis E virus

Indexed keywords

ACICLOVIR; ANIDULAFUNGIN; ANTINEOPLASTIC AGENT; CEFEPIME; FLUCONAZOLE; HEPATITIS E ANTIBODY; HYDROCORTISONE; IMMUNOGLOBULIN G ANTIBODY; LACTULOSE; MEROPENEM; PAROMOMYCIN; RITUXIMAB; VANCOMYCIN; VIRUS RNA;

ACUTE LIVER FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COLLOID; DEATH; DONOR LYMPHOCYTE INFUSION; EPISTAXIS; FATALITY; FEVER; GERMANY; GRAM POSITIVE INFECTION; HEMODIALYSIS; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INFECTION; KIDNEY FAILURE; LACTIC ACIDOSIS; MALE; MUSCLE HYPOTONIA; NUCLEOTIDE SEQUENCE; PERICARDIAL EFFUSION; PROTHROMBIN TIME; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SHOCK; SINUS TACHYCARDIA; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ACUTE DISEASE; FATAL OUTCOME; GERMANY; HEPATITIS E; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED;

EID: 84866741480     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0220-7     Document Type: Article

References (19)

1. Bächlein C, Grummer B. Hepatitis E-a new zoonotic disease in Germany? Berl Munch Tierarztl Wochenschr. 2010;123:198-204.
2. Frickmann H, Gabriel M, Polywka S, Bonow I, Günther S, Schmidt-Chanasit J. An unusual cause of elevated liver function tests in an elderly female. J Clin Virol. 2011;51:93-5. doi: 10.1016/j.jcv. 2011.02.012.
3. Pischke S, Potthoff A, Hauröder B, Schlué J, Manns MP, Corn-berg M, et al. Hepatitis E virus infection: a paradigm shift? Dtsch Med Wochenschr. 2010;135:1129-33.
4. Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298-303.
5. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lym-phoma. Hepatol Res. 2007;37:113-20.
6. Johne R, Plenge-Bönig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad spectrum RT-PCR. J Gen Virol. 2010;91:750-8.
7. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5-36.
8. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24:1484-93.
9. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med. 2006;16:79-83.
10. Lee CK, Chau TN, Lim W, Tsoi WC, Lai ST, Lin CK. Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion. Transfus Med. 2005;15:133-5.
11. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44:934-40.
12. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takah-ashi M, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74:563-72.
13. Adlhoch C, Wolf A, Meisel H, Kaiser M, Ellerbrock H, Pauli G. High HEV prevalence in four different wild boar populations in East and West Germany. Vet Microbiol. 2009;139:270-8. doi: 10.1016/j.vetmic.2009.06.032.
14. Ayoola EA, Want MA, Gadour MO, Al-Hazmi Ms H, Hamza MK. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol. 2002;66:329-34.
15. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010;31:398-407.
16. Myint KS, Gibbons RV. Hepatitis E: a neglected threat. Trans R Soc Trop Med Hyg. 2008;102:211-2.
17. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 2010;139:1612-8.
18. Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Ali Shah H, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009;3:563-70.
19. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376:895-902.